Professor of Neurology, University Utah
Neurology
Dr. Mark B. Bromberg, MD
|
|
Give Review
Mark B. Bromberg, MD is an expert in the field of Neurology. He went to University of Michigan Medical School. He received 2 awards: "America's Top Doctors" and "CMS Meaningful Use Stage 1 Certification". Mark B. Bromberg is a published doctor. He has 45 papers published. The most current publication "Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine."
Publications
- Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine.
- Practical rules for electrodiagnosis in suspected multifocal motor neuropathy.
- The cart or the horse first? Did Charcot have it right?
- Familial clustering of ALS in a population-based resource.
- The significance of significance: Overstating in the setting of many comparisons.
- An electrodiagnostic approach to the evaluation of peripheral neuropathies.
- Three cases of acute myositis in adults following influenza-like illness during the H1N1 pandemic.
- MUNIX and MUNE in ALS.
- A retrospective study of nurse-assisted propofol sedation in patients with amyotrophic lateral sclerosis undergoing percutaneous endoscopic gastrostomy.
- Amyotrophic lateral sclerosis: drug therapy from the bench to the bedside.
- Adult-onset lower extremity weakness caused by venous malformation detected by magnetic resonance imaging.
- Mining online social network data for biomedical research: a comparison of clinicians' and patients' perceptions about amyotrophic lateral sclerosis treatments.
- Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy.
- Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy.
- Nerve conduction pitfalls and pearls in the diagnosis of peripheral neuropathies.
- Electrodiagnostic assessment of peripheral neuropathies.
- An approach to the evaluation of peripheral neuropathies.
- Peripheral neuropathies. Preface.
- Effects of high-pass filtering on MUAP metrics.
- Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee.
- Optimizing acquisition time in quantitative electromyography.
- Phase II open label study of valproic acid in spinal muscular atrophy.
- The SEIQoL-DW for assessing quality of life in ALS: Strengths and limitations.
- Motor unit number estimation in the assessment of performance and function in motor neuron disease.
- Quality of life in amyotrophic lateral sclerosis.
- Assessing quality of life in ALS.
- HIV infection presenting with motor axonal variant of Guillain-Barré Syndrome.
- Chili peppers, nerve regeneration, and clinical trial design.
- Effects of intramuscular needle position on motor unit action potential metrics.
- Comparison of three algorithms for multi-motor unit detection and waveform marking.
- Drug-induced myopathies.
- Advances in diagnosis and management of inflammatory myopathies.
- Natural history of denervation in SMA: relation to age, SMN2 copy number, and function.
- The use of herbal supplements and alternative therapies by patients with amyotrophic lateral sclerosis (ALS).
- Corticosteroid use in the treatment of neuromuscular disorders: empirical and evidence-based data.
- Motor unit action potential analysis of the paraspinal muscles. Paraspinal MUAP analysis is useful.
- Assessment of axonal loss in Charcot-Marie-Tooth neuropathies.
- Counting motor units in chronic motor neuropathies.
- A rational diagnostic approach to peripheral neuropathy.
- Toward an efficient method to evaluate peripheral neuropathies.
- Stiffness, spasticity, or both: a case report of stiff-person syndrome.
- Motor unit number estimation in infants and children with spinal muscular atrophy.
- Comparison of instruments addressing quality of life in patients with ALS and their caregivers.
- Diagnostic criteria and outcome measurement of amyotrophic lateral sclerosis.
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Michigan Hospitals and Health Centers -
St Joseph Mercy Livingston Hospital -
University of Michigan Medical School
Hospital
-
University of Utah Health Care - Hospital and Clinics
Drug Facts
| NPI NUMBER | 1164517009 | |
| NPPES Provider LastName | BROMBERG | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 841320001 | |
| NPPES Provider State | UT | |
| Specialty Description | Neurology | |
| Total Claim Count | 601.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 31.0 | |
| Percent Opioid Claims | 5.16 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164517009 |
| Last Name Of The Provider | BROMBERG |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Matthew T. Sweney, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John F. Foley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dennis D. Thoen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mengjing Huan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rene J. Valles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert M. Satovick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tawnya M. Constantino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan J. Goldman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph W. Vick Roy Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel C. Abenroth, MD |
|
|
Dr. Victoria N. Holiday, MD |
|
|
Dr. Kevin T. Meier, MD |
|
|
Dr. James A. Levy, PHD |
|
|
Dr. Angela Y. Peters, MD |